These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11271405)

  • 1. Effects of nicotine on head-shakes and tryptophan metabolites.
    Gaynor CM; Handley SL
    Psychopharmacology (Berl); 2001 Jan; 153(3):327-33. PubMed ID: 11271405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome.
    Tizabi Y; Russell LT; Johnson M; Darmani NA
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1445-57. PubMed ID: 11513358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome.
    Hayslett RL; Tizabi Y
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):409-15. PubMed ID: 14643839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolinic acid inhibits DOI-induced head shakes in mice.
    Kariyawasam SH; Handley SL
    J Psychopharmacol; 1999; 13(3):284-6. PubMed ID: 10512085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM; Munzar P; Beardsley PM
    Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice.
    Suemaru K; Yasuda K; Cui R; Li B; Umeda K; Amano M; Mitsuhashi H; Takeuchi N; Inoue T; Gomita Y; Araki H
    Physiol Behav; 2006 Jul; 88(4-5):545-9. PubMed ID: 16766001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors.
    Yasuda K; Suemaru K; Araki H; Gomita Y
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):276-81. PubMed ID: 12172711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mecamylamine prevents tolerance but enhances whole brain [3H]epibatidine binding in response to repeated nicotine administration in rats.
    McCallum SE; Caggiula AR; Booth S; Breese CR; Lee MJ; Donny EC; Leonard S; Sved AF
    Psychopharmacology (Berl); 2000 May; 150(1):1-8. PubMed ID: 10867970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
    Dursun SM; Handley SL
    Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
    Khan IM; Buerkle H; Taylor P; Yaksh TL
    Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
    Janhunen S; Ahtee L
    Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.
    Rashid MH; Ueda H
    Brain Res; 2002 Oct; 953(1-2):53-62. PubMed ID: 12384238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats.
    Bednar I; Friberg L; Nordberg A
    Neurochem Int; 2004 Dec; 45(7):1049-55. PubMed ID: 15337304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of epibatidine and nicotine on the output of dopamine in the dorsal and ventral striatum of freely-moving rats.
    Seppä T; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):444-7. PubMed ID: 11111841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit.
    Dave KD; Quinn JL; Harvey JA; Aloyo VJ
    Pharmacol Biochem Behav; 2004 Mar; 77(3):623-9. PubMed ID: 15006475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicotinic receptor agonists on bladder afferent nerve activity in an in vitro bladder-pelvic nerve preparation.
    Yu Y; Daugherty SL; de Groat WC
    Brain Res; 2016 Apr; 1637():91-101. PubMed ID: 26876739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
    Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unusual nature of epibatidine responses at the alpha4beta2 nicotinic acetylcholine receptor.
    Buisson B; Vallejo YF; Green WN; Bertrand D
    Neuropharmacology; 2000 Oct; 39(13):2561-9. PubMed ID: 11044727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.